Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	27.88B +145.2%
Revenue (ttm)	1.82B -21.5%
Net Income	246.00M
EPS	0.35
Shares Out	n/a
PE Ratio	113.35
Forward PE	n/a
Dividend	0.00 (0.01%)
Ex-Dividend Date	Jun 26, 2025

Volume	2,577,661
Average Volume	3,110,606
Open	22.08
Previous Close	22.44
Day's Range	21.34 - 22.64
52-Week Range	9.36 - 28.70
Beta	1.02
RSI	41.80
Earnings Date	Mar 31, 2026

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,551
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY